Screening and predicting progression from high-risk mild cognitive impairment to Alzheimer’s disease
Abstract Individuals with mild cognitive impairment (MCI) are clinically heterogeneous, with different risks of progression to Alzheimer’s disease. Regular follow-up and examination may be time-consuming and costly, especially for MRI and PET. Therefore, it is necessary to identify a more precise MR...
Enregistré dans:
Auteurs principaux: | , , , , , , , |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/6058335ef7e5431b8d3c9d951ad243de |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|